Greenrose Acquisition Corp. (OTCQX:GNRS) said it has filed its definitive proxy statement relating to its previously announced proposed business combination and set the time and date of 9.00am Eastern Time on October 27, 2021, for its special shareholder meeting to vote on the deals.
Greenrose’s business combination will comprise its proposed merger with Connecticut-based Theraplant, LLC and the acquisition of certain assets of Arizona-based True Harvest, LLC.
It is expected that the company will proceed with its planned mergers with each of Shango Holdings, Inc. (Shango) and Futureworks LLC (d/b/a The Health Center) at a later date due to the time required to obtain state regulatory approvals.
READ: Greenrose Acquisition gearing up for massive growth potential as it closes in on deal to buy four US cannabis companies
If each transaction proposal is approved at the special meeting, the parties anticipate that the business combination will close on or about November 1, 2021, subject to the satisfaction or waiver (as applicable) of all other closing conditions.
Upon closing, the combined company will be named The Greenrose Holding Company and will continue to be listed on the OTC under the symbols GNRSU, GNRS, and GNRSW.
Greenrose also intends to list on the NEO exchange as soon as practicable after the close of the business combination.
Greenrose Acquisition is a blank check company organized for the purpose of effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more businesses or entities.
The new Greenrose Platform created by its business combination will be a multistate operator that will look to further vertically and horizontally integrate the markets that it is in and to enter new high growth and limited license markets.
Contact the author at jon.hopkins@proactiveinvestors.com